Hsiang Chi Tan
3 Papers
Hsiang Chi Tan is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Immune checkpoint inhibitors in kidney transplant recipients: a multicentre, single-arm, phase 1 study.
Robert J. Carroll,Michael Boyer,Val Gebski,Bronwyn Hockley,Julie K Johnston,Svjetlana Kireta,Hsiang Chi Tan,Anne Elizabeth Taylor,Kate Wyburn,John Zalcberg +9 more
TL;DR: Maintaining baseline immunosuppression before treatment with an immune checkpoint inhibitor in kidney transplant recipients might not affect expected efficacy and might reduce the risk of allograft rejection mediated by immune checkpoint inhibitors.
29
Difference in Cognitive Flexibility between Passive and Active Suicidal Ideation in Patients with Depression
Yi Jyunn Lai,Hsiang Chi Tan,Chin Ting Wang,Wan Chi Wu,Ling Yi Wang,Yu Chih Shen +5 more
- 01 Jan 2018
TL;DR: It is found that patients with active SI are associated with greater cognitive inflexibility than those with passive SI, which can provide insight into improved prevention.
High‐dose chemotherapy for relapsed germ cell tumours: outcomes in low‐volume specialized centres
Elizabeth Connolly,Andrew Weickhardt,Peter Grimison,Rebecca Asher,Gillian Z. Heller,Jeremy Lewin,Elizabeth Chien Hern Liow,Guy C. Toner,Iris Tung,Ben Tran,Sean Hill,Euan Walpole,J. McKenzie,Anna Kuchel,Jeffrey C. Goh,Garry Forgeson,Alvin Tan,Abhishek Joshi,Alistair Wickham,Hsiang Chi Tan,Yifang Wang,M. A. Winstanley,Nada Hamad,Vanessa Wong +23 more
TL;DR: Treatment patterns and survival outcomes of patients with relapsed and refractory metastatic germ cell tumours treated with high‐dose chemotherapy (HDCT) and autologous stem‐cell transplantation in low‐volume specialized centres within the widely dispersed populations of Australia and New Zealand between 1999 and 2019 are reported.